EOLS vs NVO
Evolus Inc (EOLS) versus NVO (NVO) — a side-by-side from cached financials, not a winner call.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
NVO (NVO) common stock.
Latest reported EOLS revenue for 2026-06-30 was $157.2M. Net income was -$18.7M. EOLS currently screens at market cap $597.0M.
NVO does not have a complete income-statement cache yet.
EOLS currently screens at market cap $597.0M. NVO currently screens at market cap $0.
Not investment advice. Open the EOLS and NVO stock pages for the full models.
Not investment advice.